IDH -mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation
Blood · 02.05.2024 · 143 (18) · 1873-1877
DOI: 10.1182/blood.2023023593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, erschienen am 02.05.2024. Verfasst von Lih En Hong und 23 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Immunity, Innate, Isocitrate Dehydrogenase, Mutation. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
High prevalence of IDH mutations in seronegative rheumatoid arthritis (RA) with myeloid neoplasm, elevated 2-hydroxyglutarate, dysregulated innate immunity, and proinflammatory microenvironment suggests causative association between IDH mutations and seronegative RA. Our findings merit investigation of IDH inhibitors as therapeutics for seronegative IDH-mutated RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia.
- Adelaide Medical School, University of Adelaide, Adelaide, Australia.
- Rheumatology Unit, Flinders Medical Centre, Adelaide, Australia.
- College of Medicine and Public Health, Flinders University, Adelaide, Australia.
- Haematology Department, Central Adelaide Local Health Network, Adelaide, Australia.
- Blood Cancer, Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia.
ORCID-Profile: Lih En Hong, Mihir D Wechalekar, Annabelle Small, Kelly Lim, Chloe Thompson-Peach, Hamish S Scott, Anna Brown, Christopher N Hahn, Salvia Sajid, Nirmal Robinson, Susan Branford, Richard J D'Andrea, Saumya E Samaraweera, Mrinal Patnaik, Susanna Proudman, Chung Hoow Kok, Mithun V Shah, Devendra K Hiwase
Förderung
- NCI NIH HHS
Zitieren
APA
Hong, L. E., Wechalekar, M. D., Kutyna, M., Small, A., Lim, K., Thompson-Peach, C., Li, J. J., Chhetri, R., Scott, H. S., Brown, A., Hahn, C. N., Yeung, D. T., Sajid, S., Robinson, N., Thomas, R., Branford, S., D'Andrea, R. J., Samaraweera, S. E., Patnaik, M., …, & Hiwase, D. K. (2024). IDH -mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation. Blood, 143(18), 1873-1877. https://doi.org/10.1182/blood.2023023593
Vancouver
Hong LE, Wechalekar MD, Kutyna M, Small A, Lim K, Thompson-Peach C, et al. IDH -mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation. Blood. 2024;143(18):1873-1877. doi:10.1182/blood.2023023593
BibTeX
@article{Hong2024,
author = {Hong, Lih En and Wechalekar, Mihir D and Kutyna, Monika and Small, Annabelle and Lim, Kelly and Thompson-Peach, Chloe and Li, Joule J and Chhetri, Rakchha and Scott, Hamish S and Brown, Anna and Hahn, Christopher N and Yeung, David T and Sajid, Salvia and Robinson, Nirmal and Thomas, Ranjeny and Branford, Susan and D'Andrea, Richard J and Samaraweera, Saumya E and Patnaik, Mrinal and Proudman, Susanna and Thomas, Daniel and Kok, Chung Hoow and Shah, Mithun V and Hiwase, Devendra K},
title = {IDH -mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation},
journal = {Blood},
year = {2024},
volume = {143},
number = {18},
pages = {1873--1877},
doi = {10.1182/blood.2023023593}
}
EUVIMED